The Arab Drug Company (EGX:ADCI)
Egypt · Delayed Price · Currency is EGP 276.47
-2.73 (-0.98%)
At close: Aug 5, 2026
The Arab Drug Company Financials Overview
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 1,326 | 1,118 | 785.52 | 633.73 | 505.04 | 537.05 |
Revenue Growth | 29.27% | 42.35% | 23.95% | 25.48% | -5.96% | 3.12% |
Gross Profit Gross Profit Growth | 516.87 | 466.28 | 265.99 | 224.35 | 185.43 | 230.3 |
Operating Income Operating Income Growth | 369.85 | 311.87 | 118.1 | 97.08 | 90.77 | 122.2 |
Net Income Net Income Growth | 229.1 | 198.93 | 88.35 | 71.13 | 76.3 | 101.41 |
Earnings Per Share EPS Growth | 19.09 | 16.58 | 7.36 | 5.93 | 5.63 | 7.33 |
EPS Growth | 44.29% | 125.18% | 24.21% | 5.28% | -23.14% | 17.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 33.05 | 79.28 | 232.72 | 50.48 | 40.28 | 60.31 |
Total Debt Total Debt Growth | 509.58 | 512.16 | 517.09 | 192.07 | 151.07 | 21.21 |
Net Cash (Debt) Net Cash Growth | -476.53 | -432.88 | -284.38 | -141.59 | -110.8 | 39.1 |
Net Cash Growth | - | - | - | - | - | -33.99% |
Net Cash Per Share Net Cash Per Share Growth | -39.71 | -36.07 | -23.70 | -11.80 | -8.18 | 2.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 236.58 | 164.28 | 135.77 | 87.51 | 32.87 | 36.58 |
Capital Expenditures CapEx Growth | -132.19 | -198.9 | -285.98 | -63.18 | -89.92 | -28.87 |
Free Cash Flow Free Cash Flow Growth | 104.4 | -34.63 | -150.22 | 24.33 | -57.04 | 7.71 |
Free Cash Flow Growth | - | - | - | - | - | -89.09% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 38.98% | 41.70% | 33.86% | 35.40% | 36.72% | 42.88% |
Operating Margin | 27.89% | 27.89% | 15.04% | 15.32% | 17.97% | 22.75% |
Pretax Margin | 25.32% | 26.36% | 16.88% | 16.84% | 19.46% | 24.38% |
Profit Margin | 17.28% | 17.79% | 11.25% | 11.22% | 15.11% | 18.88% |
FCF Margin | 7.87% | -3.10% | -19.12% | 3.84% | -11.29% | 1.44% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.167 | 4.167 | 4.175 | 2.250 | 2.400 | 2.500 |
Dividend Per Share Growth | 99.59% | -0.20% | 85.56% | -6.25% | -4.00% | 100.00% |
Dividend Yield | 1.49% | 4.28% | 11.58% | 8.06% | 13.78% | 10.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 14.62 | 6.08 | 5.46 | 5.64 | 3.61 | 3.91 |
Forward PE | - | 8.58 | 8.58 | 8.58 | 8.58 | 8.58 |
P/FCF Ratio | 32.09 | - | - | 16.49 | - | 51.48 |
PS Ratio | 2.53 | 1.08 | 0.61 | 0.63 | 0.55 | 0.74 |